Genprex to Present at the H.C. Wainwright 21st Annual Global Investment Conference
AUSTIN, Texas & CAMBRIDGE, Mass.— (September 5, 2019) — Genprex, Inc.(NASDAQ: GNPX), a clinical-stage gene therapy company, today announced that it will present at the H.C. Wainwright 21stAnnual Global Investment Conference on September 9, 2019 in New York City.
Genprex’s Chairman and Chief Executive Officer, Rodney Varner, will lead the company’s presentation and will be available for one-on-one meetings.
Genprex will present at the H.C. Wainwright 21stAnnual Global Investment Conference as follows:
Date: Monday, September 9, 2019
Time: 12:30-12:55 p.m. EDT
Venue: Lotte New York Palace Hotel, New York City
Room: Adams (4thFloor)
Several networking opportunities are still available to investors or delegates of other companies that may wish to meet the Genprex team one-on-one. Those interested in setting a meeting are asked to contact the company at [email protected].